Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Tirzepatide, also known by the brand names Mounjaro and Zepbound, is an FDA-approved dual-action GLP-1/GIP receptor agonist made by Eli Lilly
Ready to get started on your journey with Medicare
Zepbound $349499 for the medication Additional $125/month Shed Membership If approved, Shed can provide access to Zepbound (tirzepatide) in a vial, fulfilled by a dispensing pharmacy and delivered straight to your door
doi: 10.1111/dom.14496
IBS-D (diarrhea-predominant) sufferers sometimes actually report improvement in their diarrhea on semaglutide because the slowed transit normalizes their previously too-rapid motility
We are currently partnered with Deaconess Healthcare for a clinical study to look at the effects of GLP-1 Agonists (both retratrutide and semaglutide) on diabetic retinopathy, called the TRANSCEND-T2D-2 study
US$ 26.68
US$ 27.72
US$ 23.19
US$ 29.19
US$ 29.58
